Coronavirus Vaccine Human Trial to Begin This Month - (Bloomberg via NewsPoints Desk)

  • Moderna is set to begin clinical testing of its experimental COVID-19 vaccine this month, positioning it to be first among a host of shots that companies are developing to fight the outbreak, reported Bloomberg.

  • The vaccine candidate is moving very rapidly and will enter human trials "within a couple of weeks," said Richard Hatchett, chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI).

  • The estimated start of a trial of Moderna's vaccine is March 19, according to a US government website, while Hatchett indicated that Moderna's vaccine could hit Phase II testing as soon as this summer.

  • "We're working closely with Moderna, with our partners at [the US National Institutes of Health] and with regulators to make sure any vaccine that is developed…is safe and effective," he said.

  • Participants haven't yet received the vaccine, though the enrollment process has begun, the US institute said Friday, adding that the early-stage trial will be held at Kaiser Permanente Washington Health Research Institute in Seattle.

To read more NewsPoints articles, click here.